Home » Research Area » » Ion Channels » Ligand-gated Ion Channels » Glutamate (Ionotropic) Receptors » NMDA Receptors » CCMQ

CCMQ

Cat. No. 1238

Price and Availability

For CCMQ pricing & availability please select your country from the drop down menu:
Submit

By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: 2-Carboxy-3-carboxymethylquinoline

Biological Activity

For use in conjunction with [³H]-homoquinolinic acid to characterize NR2B-containing NMDA receptors; selectively inhibits [³H]-homoquinolinic acid binding to non-NMDA sensitive sites.

Technical Data

M.Wt:

231.21

Formula:

C₁₂H₉NO₄

Solubility:

Soluble to 100 mM in DMSO and to 100 mM in 1eq. NaOH with gentle warming

Storage:

Desiccate at +4°C

CAS No:

132623-44-0

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Resources

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch

Select another batch:

Safety Data Sheet: View Safety Data Sheet

References

Brown et al (1998) [³H]-Homoquinolinate binds to a subpopulation of NMDA receptors and to a novel binding site. J.Neurochem. 71 1464. PMID: 9751179.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Glutamate (Ionotropic) Receptors

NMDA Receptors

Keywords: CCMQ, supplier, characterize, NR2B-containing, NMDA, receptors, Glutamate, Receptors, N-Methyl-D-Aspartate, iGlu, Ionotropic

Quick Order

Find multiple products by catalog number

Pain Research Product Guide

Highlights over 280 products for Pain research. Request copy or view PDF today.

Therapeutic Strategies in Schizophrenia

Written by J. Lieberman

'Schizophrenia - Emerging Targets and Therapeutic Strategies' provides a summary of the targets and pathways representing the most promising strategies to pursue for novel drug development.

Calcium Imbalance and Neuroprotective Targets

Written by E. Besancon et al

'Calcium Imbalance and Neuro-protective Targets in Cerebral Ischemia & Brain Injury' highlights the key targets involved in stroke, trauma and neurodegeneration.

Neurobiology of Parkinson's Disease

Written by A. Schapira

'Neurobiology and Therapeutics of Parkinson's Disease' highlights the neurobiology of Parkinson's disease and summarizes current and novel therapeutic interventions.